Literature DB >> 25070941

Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana.

Sanghyuk S Shin1, Chawangwa Modongo2, Ronald Ncube3, Enoch Sepako4, Jeffrey D Klausner1, Nicola M Zetola5.   

Abstract

We examined factors associated with mixed-strain Mycobacterium tuberculosis infections among patients at high risk for drug-resistant tuberculosis in Botswana. Thirty-seven (10.0%) of 370 patients with tuberculosis had mixed M. tuberculosis infections, based on 24-locus mycobacterial interspersed repetitive unit-variable number of tandem repeats genotyping. In log-binomial regression analysis, age <37 years (adjusted prevalence ratio [PR], 1.92; 95% confidence interval [CI], 1.01-3.57) and prior tuberculosis treatment (adjusted PR, 2.31; 95% CI, 1.09-4.89) were associated with mixed M. tuberculosis infections. Among human immunodeficiency virus-infected patients, prior tuberculosis treatment (adjusted PR, 2.11; 95% CI, 1.04-4.31) and CD4(+) T-cell count of <100 cells/μl (adjusted PR, 10.18; 95% CI, 2.48-41.71) were associated with mixed M. tuberculosis infections. Clinical suspicion of mixed M. tuberculosis infections should be high for patients with advanced immunosuppression and a prior history of tuberculosis treatment.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV/AIDS; immune suppression; mixed tuberculosis infection; reinfection; tuberculosis

Mesh:

Year:  2014        PMID: 25070941      PMCID: PMC4351373          DOI: 10.1093/infdis/jiu421

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Microevolution of Mycobacterium tuberculosis in a tuberculosis patient.

Authors:  Sahal A M Al-Hajoj; Onno Akkerman; Ida Parwati; Saad al-Gamdi; Zeaur Rahim; Dick van Soolingen; Jakko van Ingen; Philip Supply; Adri G M van der Zanden
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

2.  Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.

Authors:  Ted Cohen; Douglas Wilson; Kristina Wallengren; Elizabeth Y Samuel; Megan Murray
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Mixed tuberculosis infections in rural South Vietnam.

Authors:  Mai N T Huyen; Kristin Kremer; Nguyen T N Lan; Frank G J Cobelens; Tran N Buu; Nguyen H Dung; Maxine Caws; Edine W Tiemersma; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

4.  The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.

Authors:  E Vynnycky; P E Fine
Journal:  Epidemiol Infect       Date:  1997-10       Impact factor: 2.451

5.  Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis.

Authors:  Evgueni Savine; Robin M Warren; Gian D van der Spuy; Nulda Beyers; Paul D van Helden; Camille Locht; Philip Supply
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

Authors:  Annelies van Rie; Thomas C Victor; Madalene Richardson; Rabia Johnson; Gian D van der Spuy; Emma J Murray; Nulda Beyers; Nico C Gey van Pittius; Paul D van Helden; Robin M Warren
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

7.  Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain.

Authors:  J-Y Wang; H-L Hsu; M-C Yu; C-Y Chiang; F-L Yu; C-J Yu; L-N Lee; P-C Yang
Journal:  Clin Microbiol Infect       Date:  2010-12-03       Impact factor: 8.067

Review 8.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

Authors:  Robert M Jasmer; Lorna Bozeman; Kevin Schwartzman; M Donald Cave; Jussi J Saukkonen; Beverly Metchock; Awal Khan; William J Burman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-11       Impact factor: 21.405

10.  Patients with active tuberculosis often have different strains in the same sputum specimen.

Authors:  Robin M Warren; Thomas C Victor; Elizabeth M Streicher; Madalene Richardson; Nulda Beyers; Nicolaas C Gey van Pittius; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

View more
  14 in total

1.  Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.

Authors:  Chao Zheng; Song Li; Zhongyue Luo; Rui Pi; Honghu Sun; Qingxia He; Ke Tang; Mei Luo; Yuqing Li; David Couvin; Nalin Rastogi; Qun Sun
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

2.  Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing.

Authors:  Max R O'Donnell; Michelle H Larsen; Tyler S Brown; Paras Jain; Vanisha Munsamy; Allison Wolf; Lorenzo Uccellini; Farina Karim; Tulio de Oliveira; Barun Mathema; William R Jacobs; Alexander Pym
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  Mixed tuberculosis infections in Northwest of Iran.

Authors:  Mohammad Asgharzadeh; Zahra Taghinejad; Behroz Mahdavipoor; Vahid Asgharzadeh; Hossein Samadi Kafil; Jalil Rashedi
Journal:  Infez Med       Date:  2021-12-10

4.  Characterization of the Proportion of Clustered Tuberculosis Cases in Guatemala: Insights from a Molecular Epidemiology Study, 2010-2014.

Authors:  María Eugenia Castellanos; Dalia Lau-Bonilla; Anneliese Moller; Eduardo Arathoon; Blanca Samayoa; Frederick Quinn; Mark Ebell; Kevin Dobbin; Christopher Whalen
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

5.  Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.

Authors:  Sanghyuk S Shin; Chawangwa Modongo; Yeonsoo Baik; Christopher Allender; Darrin Lemmer; Rebecca E Colman; David M Engelthaler; Robin M Warren; Nicola M Zetola
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

6.  Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort Study.

Authors:  Ted Cohen; Leonid Chindelevitch; Reshma Misra; Maria E Kempner; Jerome Galea; Prashini Moodley; Douglas Wilson
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

Review 7.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

8.  High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.

Authors:  Willy Ssengooba; Frank G Cobelens; Lydia Nakiyingi; Gerald Mboowa; Derek T Armstrong; Yukari C Manabe; Moses L Joloba; Bouke C de Jong
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

9.  Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.

Authors:  Laura Pérez-Lago; Miguel Martínez Lirola; Yurena Navarro; Marta Herranz; María Jesús Ruiz-Serrano; Emilio Bouza; Darío García-de-Viedma
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

10.  Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients.

Authors:  Willy Ssengooba; Bouke C de Jong; Moses L Joloba; Frank G Cobelens; Conor J Meehan
Journal:  BMC Infect Dis       Date:  2016-08-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.